Montani MA, Rodríguez CMF, Vaglio G, Torre AC, Galimberti G, Galimberti RL

Language: Spanish
References: 15
Page: 28-32
PDF size: 122.79 Kb.

ABSTRACT

Atheroembolism is a multisystemic disorder that refers to the occlusion of arteries from detachment and embolization of atheromatous debris. Most affected individuals are males, older than 60 years of age, with risk factors of atherosclerosis. Although it can occur spontaneously, atheroembolism is more commonly associated with iatrogenic manipulation via invasive vascular procedures or therapies such as anticoagulation or thrombolytics.
The most commonly affected are kidneys and skin. Skin lesions are observed in 35% to 100% of patients, and usually represent the first sign of the disease; so skin biopsy is an important diagnostic tool.
We report two cases of cholesterol embolism with skin lesions and renal failure, the former related to a cardiovascular surgery and the latter with an spontaneous onset without any known predisposing cause.

REFERENCES

1. Funabiki K, Masuoka H, Shimizu H, Emi Y, Mori T, Ito M, Nakano T. “Cholesterol crystal embolization (CCE) after cardiac catheterization”. Jpn Heart J 2003; 44(5): 767-744.

2. Dufrechou C, Cedrés S, Bruno L, Quintana M, Costa V, Bagattini J. ”Embolias de cholesterol. Caso clínico”. Rev Med Chile 2006; 134: 1442- 1447.

3. Donohue K, Saap L, Falanga V. “Cholesterol cristal embolization: An atherosclerotic disease with frequent and varied cutaneous manifestations”. JEADV 2003; 17: 504-511.

4. Manganoni A, Venturini M, Scolari F, Tucci G, Facchetti F, Graifemberghi S, Calzavara-Pinton P. “The importance of skin biopsy in the diverse clinical manifestations of cholesterol embolism”. British Journal of Dermatology 2004; 150: 1230-1232.

5. Jucgla A, Moreso F, Muniesa C, Moreno A, Vidaller A. “Cholesterol embolism: Still an unrecognized entity with a high mortality rate”. J Am Acad Dermatol 2006; 55(5): 786-793.

6. Pennington M, Yeager J, Skelton H, Smith J. “Cholesterol embolization syndrome: Cutaneous histopathological features and the variable onset of symptoms in patients with different risk factors”. British Journal of Dermatology 2002; 146: 511-517.

7. Bordel M, Álvarez J, Used M, Carrasco F. “Enfermedad por émbolos de cristales de colesterol”. Actas Dermosifiliogr 2005; 96(3): 179-181.

8. Enomae M, Takeda S, Yoshimoto K, Takagawa K. “Chronic cholesterol crystal embolism with a spontaneous onset”. The Japanese Society of Internal Medicine 2007; 1123-1126.

9. O´Leary K, Horn K. “Blue-tinged toes”. American Journal of Medicine 2005; 118: 1105-1107.

10. Rollino C, Tomasini C, Di Placido R, Aprà F, Beltrame G, Ferro M, Quattrocchio G, Massara C, Quarello F. “Cholesterol embolism after colonoscopy: A case report”. Gastrointestinal Endoscopy 2006; 63(4): 730-732.

11. Molinos S, Feal C, Gándara A, Morla J, De la Torre C, Rosón E. “Cholesterol emboli sindrome: Significance of the lesional skin biopsias”. Acta Derm Venereol 2005; 85: 527-528.

12. Koga J, Ohno M, Okamoto K, Nakasuga K, Ito H, Nagafuji K, Shimono N, Koga H, Hayashida A, Arita T, Maruyama T, Kaji Y, Harada M. “Cholesterol embolization treated with corticosteroids: Two case reports”. Angiology 2005; 56(4): 497-501.

13. Yûcel A, Karl-Kôseoghi H, Demirhan B, Ôzdemir F. “Cholesterol crystal embolization mimicking vasculitis: Success with corticosteroid and cyclophosphamide therapy in two cases”. Rheumatol Int 2006; 26: 454- 460.

14. Verneuil L, Bekolo A, Dompmartin A, Comoz F, Marcelli C, Leroy D. “Efficiency of colchicine and corticosteroids in a leg ulceration with cholesterol embolism in a woman with rheumatoid artritis”. British Society for Rheumatology 2003; 42: 1014-1016.

15. Creager M, Libby P. “Peripheral arterial diseases”. En Libby P, Bonow R, Mann D, Zipes D. Braunwald’s heart disease: A textbook of cardiovascular medicine, 8a ed. El Sevier, 2007, 1491-1505.